ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
151K |
14 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
818
|
151K
|
14
|
|
ASX - By Stock
|
1AD |
Re:
Ann: Notification of Expiry of Listed Options
|
|
64palms
|
6 |
1.1K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
6
|
1.1K
|
1
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
285
|
80K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
126
|
26K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
285
|
80K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
285
|
80K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
285
|
80K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
285
|
80K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
285
|
80K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
26K
|
3
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
151K |
5 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
818
|
151K
|
5
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
151K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
818
|
151K
|
2
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
151K |
20 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
818
|
151K
|
20
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
285
|
80K
|
0
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
26K
|
1
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
26K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
26K
|
0
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
126
|
26K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
285
|
80K
|
0
|
|
ASX - By Stock
|
PLL |
Re:
Ann: Carolina Lithium State Mining Permit
|
|
64palms
|
151 |
53K |
5 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
151
|
53K
|
5
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
151K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
818
|
151K
|
0
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
151K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
818
|
151K
|
2
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
151K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
818
|
151K
|
4
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
5 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
126
|
26K
|
5
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
126
|
26K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Ann: 3Q FY24 results update
|
|
64palms
|
460 |
82K |
11 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
460
|
82K
|
11
|
|
ASX - By Stock
|
MNB |
Re:
Ann: US$14m Loan Facility Approved & Firm Bids for Placement
|
|
64palms
|
818 |
151K |
11 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
818
|
151K
|
11
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
285
|
80K
|
1
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
285
|
80K
|
3
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
6 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
285
|
80K
|
6
|
|
ASX - By Stock
|
MNB |
Re:
Ann: Minbos Investor Presentation - Angola Rising
|
|
64palms
|
605 |
133K |
8 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
605
|
133K
|
8
|
|
ASX - By Stock
|
MNB |
Re:
Ann: Minbos Investor Presentation - Angola Rising
|
|
64palms
|
605 |
133K |
12 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
605
|
133K
|
12
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNBV MoU Webinar presentation
|
|
64palms
|
88 |
17K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
88
|
17K
|
3
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNBV MoU Webinar presentation
|
|
64palms
|
88 |
17K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
88
|
17K
|
4
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
126
|
26K
|
2
|
|
ASX - By Stock
|
1AD |
Re:
Ann: SYNThesis BioVentures MoU for cellular immunotherapies
|
|
64palms
|
126 |
26K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
126
|
26K
|
4
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
2 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
285
|
80K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
285
|
80K
|
0
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
285
|
80K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
4
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
5
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
6 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
6
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
9 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
9
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
5
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
1
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
3
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
2
|
|
ASX - By Stock
|
AEV |
Re:
Ann: Operational & Financial Update
|
|
64palms
|
285 |
80K |
6 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
285
|
80K
|
6
|
|